The use of low-dose naltrexone associated with conventional treatment in cancer patients: scoping review protocol

Paulo André Freire Magalhães

doi:10.17605/OSF.IO/6MSHP

Title	Authors

The use of low-dose naltrexone associated with conventional treatment in cancer patients: scoping review protocol

Contributors:

Paulo André Freire Magalhães

Date created: | Last Updated:

: DOI | ARK

Creating DOI. Please wait...

Create DOI

Category: Project

Description: This is a scope review using the nine stages of the JBI (Joanna Briggs Institute) for scope reviews. For Tricco et al (2018) Scoping reviews, a type of knowledge synthesis, follow a systematic approach to mapping evidence on a topic and identifying key concepts, theories, sources and knowledge gaps. The objective is to map documents on the use of low-dose naltrexone (LDN) in cancer immunomodulation.

Projects
Registrations

Results: All Projects Results: My Projects Results: All Registrations Results: My Registrations

Files

Loading files...

Citation

Recent Activity

Loading logs...

OSF does not support the use of Internet Explorer. For optimal performance, please switch to another browser.

This website relies on cookies to help provide a better user experience. By clicking Accept or continuing to use the site, you agree. For more information, see our Privacy Policy and information on cookie use.

Start managing your projects on the OSF today.

Free and easy to use, the Open Science Framework supports the entire research lifecycle: planning, execution, reporting, archiving, and discovery.

Create an Account Learn More Hide this message

Main content

Links to this project

The use of low-dose naltrexone associated with conventional treatment in cancer patients: scoping review protocol

Link other OSF projects

Files

Citation

Recent Activity

Start managing your projects on the OSF today.